ARQT
Arcutis Biotherapeutics, Inc. · Healthcare
Director Patrick J Heron bought $200K of Arcutis Biotherapeutics, Inc.
Bought$199,994
$9.50Price
21,052Shares
What ARQT did for a copier
- $1,000 copied at Thu, Mar 7 open, $10.54
- $864
- S&P 500, same days
- −3.2%
Measured over 30 trading days, to the Apr 19 close.
Patrick J Heron's record
15 other buys with 3 months of prices since 2020: on average +8.4% against the S&P 500, and 10 of 15 beat it.
We're building an app that can copy buys like this into your own brokerage. Join the waitlist
Traded Mon, Mar 4. Filed Wed, Mar 6, 4:28 PM ET, after the close. Returns use the Mar 7 open and the Apr 19 close. Not investment advice.